21 Sept 2023
STRM.BIO to Present at 2023 Cell & Gene Meeting on the Mesa

15 Sept 2023
Guest Column: CEO Jonathan Thon and VP of R&D Laura Goldberg talk about the Value of Repeat Dosing in Gene Therapy at Cell & Gene

24 July 2023
STRM.BIO Appoints Independent Director Minnie Mildwoff to its Board of Directors

31 May 2023
CEO Jonathan Thon talks with Inside Precision Medicine about Challenges in Gene Therapy Delivery

17 May 2023
STRM.BIO Appoints Independent Director Dawn Bell, PharmD, to its Board

13 December 2022
Roundtable: Cell and Gene Therapy in a World of Turmoil

11 December 2022
BIOS Podcast: Interview with CEO Jonathan Thon

13 October 2022
Op-Ed: A Good Culture Keeps Good People

17 August 2022
Q&A with CEO Jonathan Thon featured in Inside Precision Medicine

26 July 2022
STRM.BIO Receives $2.1 Million SBIR Grant to Advance Extracellular Vesicle Technology for Non-Viral, In Vivo Delivery of Gene Therapies

13 June 2022
STRM.BIO Appoints Vanessa Salazar as Vice President of Business Development

19 January 2022
STRM.BIO recruits technology leader to help bring gene therapy to life